Rajshekhar Chakraborty, MD
2 clinical trials · Sponsor
◉ Watch Rajshekhar Chakraborty, MD
| Record | Firm | Date |
|---|---|---|
| Teclistamab-Daratumumab in AL Amyloidosis (NCT07110844) | Rajshekhar Chakraborty, MD | 2025-11-07 |
| Non-invasive MRD Assessment in Multiple Myeloma (NCT05625971) | Rajshekhar Chakraborty, MD | 2022-09-14 |
Track Rajshekhar Chakraborty, MD automatically
Every clearance here is in the API, with alerts when new ones post.